Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$83.14 - $145.99 $12.8 Million - $22.6 Million
-154,500 Reduced 88.34%
20,400 $2.97 Million
Q1 2022

May 13, 2022

SELL
$110.08 - $142.92 $7.42 Million - $9.63 Million
-67,400 Reduced 27.82%
174,900 $20.7 Million
Q4 2021

Feb 11, 2022

BUY
$99.73 - $148.48 $21.7 Million - $32.3 Million
217,300 Added 869.2%
242,300 $33.4 Million
Q3 2021

Nov 12, 2021

SELL
$98.85 - $138.91 $6.43 Million - $9.03 Million
-65,000 Reduced 72.22%
25,000 $3.47 Million
Q2 2021

Aug 16, 2021

BUY
$65.78 - $105.02 $841,984 - $1.34 Million
12,800 Added 16.58%
90,000 $8.74 Million
Q4 2020

Feb 16, 2021

BUY
$65.07 - $98.24 $3.07 Million - $4.64 Million
47,200 Added 157.33%
77,200 $6.62 Million
Q3 2020

Nov 16, 2020

SELL
$59.04 - $77.95 $27.4 Million - $36.2 Million
-464,500 Reduced 93.93%
30,000 $1.95 Million
Q2 2020

Aug 14, 2020

BUY
$29.01 - $74.23 $8.18 Million - $20.9 Million
282,000 Added 132.71%
494,500 $36.2 Million
Q1 2020

May 15, 2020

SELL
$27.51 - $57.29 $11.2 Million - $23.2 Million
-405,800 Reduced 65.63%
212,500 $7.23 Million
Q4 2019

Feb 13, 2020

BUY
$40.86 - $57.65 $2.8 Million - $3.95 Million
68,600 Added 12.48%
618,300 $33.7 Million
Q3 2019

Nov 14, 2019

BUY
$37.38 - $49.47 $5.9 Million - $7.81 Million
157,900 Added 40.3%
549,700 $22.9 Million
Q2 2019

Aug 13, 2019

BUY
$39.79 - $67.01 $15.6 Million - $26.3 Million
391,800 New
391,800 $17.2 Million

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.